Website
View Website
BS, Clarke University
PhD, University of Notre Dame
Postgraduate Fellowship, University of Notre Dame
Postdoctoral Researcher, University of Wisconsin-Madison
- Soy Protein Isolate Affects Blood and Brain Biomarker Expression in a Mouse Model of Fragile X
- Soy-based purified ingredient diet affects mouse gut permeability and the microbiome in fragile X mice
- Prophylactic or Poison: The Folic Acid Debate
- Bibliometric Analysis and a Call for Increased Rigor in Citing Scientific Literature: Folic Acid Fortification and Neural Tube Defect Risk as an Example
- Adult Inception of Ketogenic Diet Therapy Increases Sleep during the Dark Cycle in C57BL/6J Wild Type and Fragile X Mice
- Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice
- On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model
- Toward an understanding of the role of the exposome on fragile X phenotypes
- Ketogenic Diet Affects Sleep Architecture in C57BL/6J Wild Type and Fragile X Mice
- Diet in treatment of autism spectrum disorders
- Improving Reproducibility to Enhance Scientific Rigor through Consideration of Mouse Diet
- Increased Incidence of Epilepsy in Response to Soy-Based Infant Formula in a National Korean Cohort Study
- Effects of Soy-Based Infant Formula on Weight Gain and Neurodevelopment in an Autism Mouse Model
- Testing <em>Fmr1</em> <sup><em>KO</em></sup> Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
- Parental Reports on Early Autism Behaviors in Their Children with Fragile X Syndrome as a Function of Infant Feeding
Dr. Westmark’s basic and translational science research laboratory studies pharmaceutical and dietary interventions for the treatment of fragile X syndrome, autism and Alzheimer’s disease with a focus on the synaptic function of amyloid beta protein precursor (APP) and amyloid-beta. She employs mouse models of neurological disorders and human survey data to correlate promising treatments with improved behavioral (seizure, cognitive, hyperactivity/sleep) and biomarker data.
Lily’s Fund Fellow (2022)
Distance Teaching & Learning scholarship winner, UW-Madison (2019)
Brain Research Foundation Seed Grant Program finalist (2018)